It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Posted by ApollonianFunMachine
what do you all think of this? I think these pages need to be preserved before they get spread far enough to be removed from view. Briefly, I will tell you how I came across this information, and some other startling revelations I stumbled onto afterwards. I was talking with a friend earlier about the patents issued for the swine flu viruses, and why I think the information on patents is the cornerstone for understanding why so many are deeply suspicious of the events surrounding this current "pandemic". He asked me what I knew about the patents and what information I could share, and I quickly did a search and found the usual info that is circulating regarding Baxter's and Novartis' patents. Somehow, in a roundabout way I then came upon a site entitle "patentstorm", did a search for swine flu, and came across the following: www.patentstorm.us... I've copied and pasted most of the rest of this document to the end of this email. Obviously, I was pretty stunned by what I was reading, and the timing of the application and publication. I'm not going to go into everything I've found because it's time-consuming, and because I feel that others might have much more experienced researchers, resources, and contacts than I do. I will briefly share one thing I've turned up in a very brief period of time. Luckily, this document contains the names of the researchers who've filed it, which I will include here. I decided to look some of them up to see if I could find anything out about their careers online. Here is that information: Inventors * Palese, Peter * Garcia-Sastre, Adolfo * Webby, Richard J. * Richt, Juergen A. * Webster, Robert G. * Lager, Kelly M. Assignees * THE UNITED STATED OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE * St. Jude Children's Research Hospital * MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY Hopefully your team can take over from here if you deem any of this to be pertinent information. I will point out that I looked up Richard J. Webby, and found that he has worked for the WHO and St Jude. Here is a brief bio stating his responsibilities and mention that he has been travelling to Switzerland (home of Novartis) " twice a year to participate in vaccine strain selection meetings". The bio can be found here, and it dates to Feb 2008. Of particular interest are the last two paragraphs: www.stjude.org... Now the real reason I've found Webby interesting is his name also brought me to a previous article, which I believe Alex Jhas mentioned on the show. I will also post the link to that article and the brief excerpt THAT JUMPED OFF THE PAGE AT ME. The reason is the wording that was used --- "they created a PANDEMIC" etc. scitizen.com... suring-/ 11 Sep, 2006 Researchers from the Center for Disease Control and Prevention (CDC) in Atlanta, USA, have combined bird and human flu viruses in order to create a pandemic strain. They reported recently that the hybrid viruses are, at least for ferrets, relatively benign . Richard Webby, virologist at the St. Jude Children's Research Hospital, comments on these results for Scitizen. Why is it interesting to combine genes from human flu virus and the H5N1 bird flu strain? What scenario is being tested? One of the reasons why we don’t have a lot of human pandemics with these avian strains is that they don’t generally grow very well in humans or transmit between them. One way that we know that these avian viruses can adapt to humans is by getting together with a human virus and mixing gene segments. If we look back at the last 2 human pandemics, the 1967 Asian Flu and the 1968 Hong Kong Flu, those those viruses
Claims 1. An attenuated swine influenza virus comprising a mutation in a swine influenza NS1 gene that diminishes the ability of the NS1 gene product to antagonize the cellular interferon response, and permits the attenuated virus, at a multiplicity of infection of 0.001, to grow to titers between approximately 3 fold to approximately 7 fold lower than wild-type swine influenza in pig cells, as determined approximately 5 days post-infection when propagated under the same conditions. 2. The attenuated swine influenza virus of claim 1, wherein the attenuated virus is genetically engineered. 3. The attenuated swine influenza virus of claim 1, wherein the attenuated virus is a mutagenized virus or reassortant. 4. The attenuated swine influenza virus of claim 2, wherein the attenuated virus is a chimeric virus that expresses a heterologous sequence. 5. The attenuated swine influenza virus of claim 2, wherein the attenuated virus is a chimeric virus that expresses a tumor antigen. 6. The attenuated swine influenza virus of claim 2, wherein the attenuated virus is a chimeric virus that expresses an epitope of a foreign pathogen. 7. The attenuated swine influenza virus of claim 1, wherein pig cells are PK(D1) cells, PK(15) cells, PK13 cells, NSK cells, LLC-PK1 cells, LLC-PK1A cells, ESK-4 cells, ST cells, PT-K75 cells, PK-2a/CL 13 cells or SJPL cells. 8. (canceled) 9. The attenuated swine influenza virus of claim 2, wherein the mutation is a deletion at the carboxy terminus of the NS1 gene. 10. (canceled) 11. An attenuated swine influenza virus comprising a modified NS1 gene, wherein the attenuated swine influenza virus is TX/98/del 126, TX/98/del 99 or TX/98/del 73. 12. An attenuated swine influenza virus having an altered interferon antagonist phenotype, wherein said virus comprises a mutation in the NS1 gene resulting in a deletion of between the 105 carboxy terminal amino acid residues and the 160 carboxy terminal amino acid residues of NS1. 13. The attenuated swine influenza virus of claim 12, wherein the virus is attenuated by a mutation in the NS1 gene resulting in a deletion of all of the amino acid residues of NS1 except amino acid residues 1-95, amino acid residues 1-90, amino acid residues 1-85, amino acid residues 1-80, amino acid residues 1-75, amino acid residues 1-73, amino acid residues 1-70, amino acid residues 1-65, or amino acid residues 1-60, and wherein the amino terminal amino acid is number 1 and the mutation in the NS1 gene confers an altered interferon antagonist phenotype. 14. (canceled)
Originally posted by Drunkenshrew
Link to scientists who hold the patent:
1. Robert G. Webster (holds also a high position within the WHO)
2. Dr. Jürgen A. Richt
3. Richard J. Webby
4. Peter Palese
5. Adolfo García-Sastre
Patents from 1790 through 1975 are searchable only by Issue Date, Patent Number, and Current US Classification.
When searching for specific numbers in the Patent Number field, patent numbers must be seven characters in length, excluding commas, which are optional.